Type 2 diabetes: the many facets of care.
A review of Type 2 diabetes mellitus is presented. Lifestyle recommendations with a focus on currently available medications are discussed. A case study involving a patient with diabetes mellitus and a foot ulcer is discussed in relation to current treatment recommendations.
Hall
Mellisa A
MA
University of Southern Indiana, Evansville, Indiana, USA. mhall@usi.edu
D000328:Adult; D000682:Amyloid / Q000627:therapeutic use; D001645:Biguanides / Q000627:therapeutic use; D003152:Community Health Nursing / Q000379:methods*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism / Q000517:prevention & control*; D017719:Diabetic Foot / Q000209:etiology / Q000517:prevention & control*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use; D000077270:Exenatide; D006442:Glycated Hemoglobin / Q000378:metabolism; D065089:Glycoside Hydrolase Inhibitors; D006699:Home Care Services; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D058228:Islet Amyloid Polypeptide; D008019:Life Style; D008297:Male; D010353:Patient Education as Topic; D010455:Peptides / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000627:therapeutic use; D014688:Venoms / Q000627:therapeutic use; D014945:Wound Healing
D000682:Amyloid; D001645:Biguanides; D054873:Dipeptidyl-Peptidase IV Inhibitors; D000077270:Exenatide; D006442:Glycated Hemoglobin; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D058228:Islet Amyloid Polypeptide; D010455:Peptides; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; D014688:Venoms; C105254:pramlintide